(1R,2S,5S,8S,9S,14R,15R,17R,18R,21S,24R,26S,27S)-14-chloro-5,15-dihydroxy-2,9,26-trimethyl-3,19,23,28-tetraoxaoctacyclo[16.9.1.118,27.01,5.02,24.08,17.09,14.021,26]nonacos-11-ene-4,10,22,29-tetrone

Details

Top
Internal ID 25c55814-8e04-44d2-a58b-41336ea2cc08
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Physalins and derivatives
IUPAC Name (1R,2S,5S,8S,9S,14R,15R,17R,18R,21S,24R,26S,27S)-14-chloro-5,15-dihydroxy-2,9,26-trimethyl-3,19,23,28-tetraoxaoctacyclo[16.9.1.118,27.01,5.02,24.08,17.09,14.021,26]nonacos-11-ene-4,10,22,29-tetrone
SMILES (Canonical) CC12CC3C4(C56C1C(=O)C(O5)(C7CC(C8(CC=CC(=O)C8(C7CCC6(C(=O)O4)O)C)Cl)O)OCC2C(=O)O3)C
SMILES (Isomeric) C[C@]12C[C@@H]3[C@]4([C@]56[C@H]1C(=O)[C@](O5)([C@@H]7C[C@H]([C@]8(CC=CC(=O)[C@@]8([C@H]7CC[C@]6(C(=O)O4)O)C)Cl)O)OC[C@H]2C(=O)O3)C
InChI InChI=1S/C28H31ClO10/c1-22-10-17-24(3)28-18(22)19(32)27(39-28,36-11-14(22)20(33)37-17)13-9-16(31)25(29)7-4-5-15(30)23(25,2)12(13)6-8-26(28,35)21(34)38-24/h4-5,12-14,16-18,31,35H,6-11H2,1-3H3/t12-,13+,14-,16+,17+,18-,22+,23-,24-,25-,26+,27+,28-/m0/s1
InChI Key YNEPXUIPALKHAU-IFSNGKJOSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C28H31ClO10
Molecular Weight 563.00 g/mol
Exact Mass 562.1605749 g/mol
Topological Polar Surface Area (TPSA) 146.00 Ų
XlogP 0.40
Atomic LogP (AlogP) 0.97
H-Bond Acceptor 10
H-Bond Donor 2
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1R,2S,5S,8S,9S,14R,15R,17R,18R,21S,24R,26S,27S)-14-chloro-5,15-dihydroxy-2,9,26-trimethyl-3,19,23,28-tetraoxaoctacyclo[16.9.1.118,27.01,5.02,24.08,17.09,14.021,26]nonacos-11-ene-4,10,22,29-tetrone

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9823 98.23%
Caco-2 - 0.7435 74.35%
Blood Brain Barrier + 0.7000 70.00%
Human oral bioavailability - 0.6714 67.14%
Subcellular localzation Mitochondria 0.7354 73.54%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8083 80.83%
OATP1B3 inhibitior + 0.8972 89.72%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.5250 52.50%
BSEP inhibitior + 0.8649 86.49%
P-glycoprotein inhibitior + 0.6378 63.78%
P-glycoprotein substrate + 0.6606 66.06%
CYP3A4 substrate + 0.7449 74.49%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8944 89.44%
CYP3A4 inhibition - 0.9377 93.77%
CYP2C9 inhibition - 0.8863 88.63%
CYP2C19 inhibition - 0.9158 91.58%
CYP2D6 inhibition - 0.9412 94.12%
CYP1A2 inhibition - 0.8798 87.98%
CYP2C8 inhibition + 0.6223 62.23%
CYP inhibitory promiscuity - 0.9746 97.46%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.8638 86.38%
Carcinogenicity (trinary) Danger 0.4498 44.98%
Eye corrosion - 0.9881 98.81%
Eye irritation - 0.9277 92.77%
Skin irritation - 0.5884 58.84%
Skin corrosion - 0.8873 88.73%
Ames mutagenesis - 0.6870 68.70%
Human Ether-a-go-go-Related Gene inhibition - 0.4843 48.43%
Micronuclear - 0.8500 85.00%
Hepatotoxicity + 0.6500 65.00%
skin sensitisation - 0.8819 88.19%
Respiratory toxicity + 0.8667 86.67%
Reproductive toxicity + 0.7667 76.67%
Mitochondrial toxicity + 0.7750 77.50%
Nephrotoxicity + 0.6836 68.36%
Acute Oral Toxicity (c) III 0.4687 46.87%
Estrogen receptor binding + 0.8312 83.12%
Androgen receptor binding + 0.7903 79.03%
Thyroid receptor binding + 0.6339 63.39%
Glucocorticoid receptor binding + 0.7982 79.82%
Aromatase binding + 0.7831 78.31%
PPAR gamma + 0.5800 58.00%
Honey bee toxicity - 0.6764 67.64%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity + 0.5800 58.00%
Fish aquatic toxicity + 0.9879 98.79%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 95.59% 97.25%
CHEMBL218 P21554 Cannabinoid CB1 receptor 95.02% 96.61%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.88% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 94.33% 94.45%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 92.89% 85.14%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.85% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.65% 97.09%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 91.08% 97.14%
CHEMBL1994 P08235 Mineralocorticoid receptor 90.77% 100.00%
CHEMBL1871 P10275 Androgen Receptor 89.82% 96.43%
CHEMBL1806 P11388 DNA topoisomerase II alpha 87.41% 89.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 87.34% 95.89%
CHEMBL4481 P35228 Nitric oxide synthase, inducible 86.42% 94.80%
CHEMBL221 P23219 Cyclooxygenase-1 85.92% 90.17%
CHEMBL4208 P20618 Proteasome component C5 85.26% 90.00%
CHEMBL4803 P29474 Nitric-oxide synthase, endothelial 84.96% 86.00%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 84.37% 96.77%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.21% 95.56%
CHEMBL259 P32245 Melanocortin receptor 4 83.28% 95.38%
CHEMBL2581 P07339 Cathepsin D 81.81% 98.95%

Cross-Links

Top
PubChem 10769263
NPASS NPC79835